John Risner, President of the Children's Tumor Foundation, presides over the closing bell.

Tuesday, May 8, 2007
from the Nasdaq Stock Market
in New York's Times Square

The Children's Tumor Foundation

Founded in 1978, The Children's Tumor Foundation is dedicated to improving the health and well being of more than 100,000 Americans living with neurofibromatosis (NF). Our research program has played a key role in the discovery of the genes that cause NF, understanding the biology of NF, creation of The NF Clinic Network and preclinical screening of promising drug compounds to treat the disorder.

NF is a genetic disorder that causes tumors to grow on nerve endings throughout the body. Occurring in 1-3,000 births, NF is more prevalent than cystic fibrosis, Huntington's disease and Duchenne muscular dystrophy combined. Ranging in severity, NF can lead to loss of vision and hearing, disfigurement, skeletal defects, learning disabilities and various forms of cancer, including juvenile leukemia.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 05/08/2007 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: John Risner, President of the Children's Tumor Foundation, rings the closing bell. These photos are Copyright 2007, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2007, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.